6 research outputs found
Dissecting cell identity via network inference and in silico gene perturbation
Cell identity is governed by the complex regulation of gene expression, represented as gene-regulatory network
F2-isoprostanes can mediate bleomycin-induced lung fibrosis
F2-isoprostanes (F2-IsoPs) have been considered markers of oxidative stress in various pulmonary diseases, but
little is known about their possible role in pulmonary fibrosis. In this study, we have investigated the potential
key role of F2-IsoPs as markers and mediators of bleomycin (BLM)-induced pulmonary fibrosis in rats. During the
in vivo study, plasma F2-IsoPs showed a peak at 7 days and remained elevated for the entire experimental period.
Lung F2-IsoP content nearly tripled 7 days following the intratracheal instillation of BLM, and by 28 days, the
value increased about fivefold compared to the controls. Collagen deposition correlated with F2-IsoP content in
the lung. Furthermore, from day 21 onwards, lung sections from BLM-treated animals showed α-smooth muscle
actin (α-SMA) positive cells, which were mostly evident at 28 days. In vitro studies performed in rat lung fibroblasts
(RLF) demonstrated that either BLM or F2-IsoPs stimulated both cell proliferation and collagen
synthesis. Moreover, RLF treated with F2-IsoPs showed a significant increase of α-SMA expression compared to
control, indicating that F2-IsoPs can readily activate fibroblasts to myofibroblasts. Our data demonstrated that
F2-IsoPs can be mediators of key events for the onset and development of lung fibrosis, such as cell proliferation,
collagen synthesis and fibroblast activation. Immunocytochemistry analysis, inhibition and binding studies
demonstrated the presence of the thromboxane A2 receptor (TP receptor) on lung fibroblasts and suggested that
the observed effects may be elicited through the binding to this receptor. Our data added a new perspective on
the role of F2-IsoPs in lung fibrosis by providing evidence of a profibrotic role for these mediators in the pathogenesis
of pulmonary fibrosis
Animal models for anti-emphysema drug discovery
Introduction. Emphysema is characterized by an abnormal, permanent enlargement of airspaces accompanied by destruction of their walls. Up to now, there is no cure for emphysema and animal models may be important for new drug discovery.
Areas covered. Herein, the authors review animal models of emphysema since the protease-antiprotease hypothesis as well as the results obtained with compounds tested in these models. Of particular importance are animal models of cigarette smoke (CS) exposure, since CS is the most important risk factor of emphysema. The authors also analyze two approaches to drugs testing, i.e. the approach aimed at preventing emphysema and the one aimed at reversing it.
Expert opinion. It has been suggested that early and late interventions do not have the same protective effect and that late interventions are much more likely to reveal treatments beneficial in humans. However, this is not always the case and a compound which prevents emphysema when administered as an early intervention can also have the same protective effect when given as a late intervention. Furthermore, the fact that a compound detected by means of early intervention is now in clinical practice shows that early intervention studies can be predictive for efficacy in humans
A short Mindfulness retreat can improve biological markers of stress and inflammation
Objective: Mindfulness practice, a form of meditation, has shown benefit for psychological and physical health. In this study, we investigated the effect of an intensive period of Mindfulness practice on some biological mediators of stress and inflammation during a 3-day residential retreat. Methods: A total of 95 healthy individuals (aged 18-67) were recruited and randomized to a Mindfulness retreat arm or an active control arm. Before (t0) and after (t1) the intervention, all the participants were assessed for salivary cortisol levels and for a panel of pro- and anti-inflammatory cytokines measured in saliva. Psychometric measures on stress, anxiety and awareness were carried out using PSS, STAI-Y and MAAS questionnaires, respectively. Results: As to the within-group differences, we observed a statistically significant decrease in perceived stress (beta = - 8.85, p < 0.0001), and anxiety scores (beta = - 12.39, p < 0.0001), while awareness increased (beta = 15.26, p < 0.0001) between t0 to t1 in retreat participants. In the mindfulness intervention group, we also observed a statistically significant reduction in the levels of pro-inflammatory cytokines IL-6 (beta = - 0.94 p = 0.001) and IL8 (beta = - 176.40, p < 0.0001), and an increase in anti-inflammatory IL-10 (beta = 0.89 p < 0.0001) levels at the end of the retreat. At t1 we observed a highly significant correlation between cortisol levels and both anxiety (r = 0.56, p < 0.0001) and perceived stress (r = 0.92, p < 0.0001) scores. Conclusions: Mindfulness retreat participants showed a significant reduction in perceived stress and anxiety levels, as well as an improved balance of some key mediators of inflammatory states. Our data provide evidence that a mindfulness retreat may be effective in improving physical and mental health. Future studies with larger numbers of subjects and follow-up periods may examine mindfulness practice as a non-pharmacological alternative to promote stress reduction and overall health and wellbeing
Quercetin reduced inflammation and increased antioxidant defense in rat adjuvant arthritis.
Inherited determinants of early recurrent somatic mutations in prostate cancer.
Prostate cancer is a highly heritable molecularly and clinically heterogeneous disease. To discover germline events involved in prostate cancer predisposition, we develop a computational approach to nominate heritable facilitators of somatic genomic events in the context of the androgen receptor signaling. Here, we use a ranking score and benign prostate transcriptomes to identify a non-coding polymorphic regulatory element at 7p14.3 that associates with DNA repair and hormone-regulated transcript levels and with an early recurrent prostate cancer-specific somatic mutation in the Speckle-Type POZ protein (SPOP) gene. The locus shows allele-specific activity that is concomitantly modulated by androgen receptor and by CCAAT/enhancer-binding protein (C/EBP) beta (CEBPB). Deletion of this locus via CRISPR-Cas9 leads to deregulation of the genes predicted to interact with the 7p14.3 locus by Hi-C chromosome conformation capture data. This study suggests that a polymorphism at 7p14.3 may predispose to SPOP mutant prostate cancer subclass through a hormone-dependent DNA damage response.Prostate cancer is a heterogeneous disease, and many cases show somatic mutations of SPOP. Here, the authors show that a non-coding polymorphic regulatory element at 7p14.3 may predispose to SPOP mutant prostate cancer subclass through a hormone dependent DNA damage response